Skip to main content

Menu

Select a tool from the sidebar

Create your free account now!

Sign in to customize and use tools on the sidebar.

Sign InCreate free account
Cochlear Limited logo
COH.AX
Cochlear Limited
06:10:08
118.14 A$
0.0000 (%0.00)
Previous Close: 114.29
Day Low₺113.04
Day High₺118.14
Bid
Ask
Overview
Technicals
Financial Statements
Comments
Archive

COH.AX: Cochlear Limited Financials

Cochlear Limited Income Statement

Total revenue
Net income
Gross margin TTM
73.74%
Operating margin TTM
17.33%
Net profit margin TTM
16.6%
Return on investment TTM
19.94%
Period end30/06/202530/06/202430/06/202330/06/2022
Total revenue2,343,100,0002,235,600,0001,936,100,0001,641,100,000
Operating income406,100,000521,500,000389,500,000361,700,000
Net income388,900,000356,800,000300,600,000289,100,000

All line items

Line item30/06/202530/06/202430/06/202330/06/2022
Total revenue2,343,100,0002,235,600,0001,936,100,0001,641,100,000
Cost of revenue615,200,000562,100,000488,000,000411,000,000
Gross profit1,727,900,0001,673,500,0001,467,700,0001,230,100,000
Research and development expenses291,500,000277,000,000244,900,000210,700,000
General and administrative expenses207,900,000212,600,000203,900,000159,000,000
Selling and marketing expenses732,000,000685,000,000606,500,000498,700,000
Selling, general and administrative expenses939,900,000897,600,000810,400,000657,700,000
Other expenses90,400,00084,900,0003,300,00073,000,000
Operating expenses1,321,800,0001,259,500,0001,055,300,000941,400,000
Cost and expenses1,937,000,0001,821,600,0001,624,200,0001,352,400,000
Net interest income700,0009,800,0007,100,000-6,200,000
Interest income11,700,00019,000,00016,500,0002,400,000
Interest expense11,000,0009,200,0009,400,0008,600,000
Depreciation and amortization90,400,00084,900,00080,900,00073,000,000
EBITDA619,900,000579,500,000487,100,000475,400,000
EBIT529,500,000494,000,000406,000,000402,400,000
Non-operating income (excl. interest)-123,400,00027,500,0006,400,000-40,700,000
Operating income406,100,000521,500,000389,500,000361,700,000
Total other income/expenses (net)112,400,0009,800,0007,100,00032,100,000
Income before tax518,500,000484,800,000396,800,000393,800,000
Income tax expense129,600,000128,000,00096,000,000104,700,000
Net income from continuing operations388,900,000356,800,000300,600,000289,100,000
Net income from discontinued operations0000
Other adjustments to net income0000
Net income388,900,000356,800,000300,600,000289,100,000
Net income deductions0000
Bottom line net income388,900,000356,800,000300,600,000289,100,000
EPS6554
Diluted EPS6554
Weighted average shares outstanding65,438,09965,537,00065,770,00065,733,000
Weighted average diluted shares outstanding65,438,09965,709,00065,897,00065,771,000

Cochlear Limited Balance Sheet

Total assets
Total liabilities & equity
Liquidity ratio MRQ
—
Current ratio MRQ
—
Long-term debt / assets MRQ
0%
Total debt / assets MRQ
—
Period end30/06/202530/06/202430/06/202330/06/2022
Total assets2,825,000,0002,745,100,0002,568,700,0002,465,100,000
Total liabilities874,700,000904,600,000819,900,000779,400,000
Total equity1,950,300,0001,840,500,0001,748,800,0001,685,700,000

All line items

Line item30/06/202530/06/202430/06/202330/06/2022
Cash and cash equivalents275,700,000513,600,000555,500,000629,300,000
Short-term investments0000
Cash and short-term investments275,700,000513,600,000555,500,000629,300,000
Net receivables585,900,000490,700,000457,500,000390,400,000
Accounts receivable514,700,000425,300,000437,500,000308,400,000
Other receivables71,200,00065,400,00020,000,00082,000,000
Inventory499,400,000391,600,000311,500,000270,200,000
Prepaid expenses37,100,00037,200,00033,300,00028,700,000
Other current assets18,700,00019,000,0003,700,0008,400,000
Total current assets1,416,800,0001,452,100,0001,361,500,0001,327,000,000
Property, plant and equipment (net)536,200,000517,200,000447,200,000439,200,000
Goodwill278,600,000257,700,000256,100,000257,100,000
Intangible assets222,200,000193,300,000444,100,000392,500,000
Goodwill and intangible assets500,800,000451,000,000700,200,000649,600,000
Long-term investments78,900,00083,400,000190,600,000190,300,000
Tax assets168,700,000138,700,000125,300,000116,100,000
Other non-current assets123,600,000102,700,000-256,100,000-257,100,000
Total non-current assets1,408,200,0001,293,000,0001,207,200,0001,138,100,000
Other assets0000
Total assets2,825,000,0002,745,100,0002,568,700,0002,465,100,000
Total payables298,400,000320,800,000287,900,000247,600,000
Accounts payable298,400,000303,200,000270,400,000232,400,000
Other payables26,400,00017,600,00035,000,00030,400,000
Accrued expenses0150,500,000146,400,000101,600,000
Short-term debt00042,600,000
Capital lease obligations (current)42,200,00041,600,00039,200,00036,100,000
Tax payables017,600,00017,500,00015,200,000
Deferred revenue80,400,00066,700,00061,600,00054,700,000
Other current liabilities181,300,00051,900,00042,900,00045,000,000
Total current liabilities602,300,000631,500,000578,000,000527,600,000
Long-term debt0000
Capital lease obligations (non-current)193,500,000202,100,000162,600,000175,200,000
Deferred revenue (non-current)3,500,0008,600,0009,800,0007,800,000
Deferred tax liabilities (non-current)18,000,00018,900,00018,300,00022,400,000
Other non-current liabilities57,400,00043,500,00051,200,00046,400,000
Total non-current liabilities272,400,000273,100,000241,900,000251,800,000
Other liabilities0000
Capital lease obligations235,700,000243,700,000201,800,000211,300,000
Total liabilities874,700,000904,600,000819,900,000779,400,000
Treasury stock0000
Preferred stock0000
Common stock1,176,000,0001,204,200,0001,250,300,0001,276,600,000
Retained earnings777,300,000667,900,000555,400,000455,300,000
Additional paid-in capital0000
Accumulated other comprehensive income/loss-3,000,000-31,600,000-56,900,000-46,200,000
Other stockholders' equity0000
Total stockholders' equity1,950,300,0001,840,500,0001,748,800,0001,685,700,000
Total equity1,950,300,0001,840,500,0001,748,800,0001,685,700,000
Minority interest0000
Total liabilities and total equity2,825,000,0002,745,100,0002,568,700,0002,465,100,000
Total investments78,900,00083,400,000190,600,000190,300,000
Total debt235,700,000243,700,000201,800,000253,900,000
Net debt-40,000,000-269,900,000-353,700,000-375,400,000

Cochlear Limited Cash Flow Statement

Cash from operations
Cash from investing
Cash flow / share TTM
—
Revenue / share TTM
—
Operating cash flow TTM
—
Period end30/06/202530/06/202430/06/202330/06/2022
Cash from operations237,600,000388,800,000362,400,000376,500,000
Cash from investing-115,200,000-105,700,000-125,700,000-138,900,000
Cash from financing-366,900,000-323,800,000-310,400,000-220,700,000
Net change in cash-237,900,000-41,900,000-73,800,00019,700,000

All line items

Line item30/06/202530/06/202430/06/202330/06/2022
Net income388,900,000356,800,000300,600,000289,100,000
Depreciation and amortization90,400,00084,900,00080,900,00073,000,000
Deferred income tax00-14,800,00045,000,000
Stock-based compensation0015,900,00010,800,000
Change in working capital-267,200,000-74,600,000-27,600,000-23,000,000
Accounts receivable-101,700,000-53,600,000-89,000,000-52,200,000
Inventory-107,800,000-80,100,000-41,300,000-54,100,000
Accounts payable-4,800,00032,799,99937,700,00029,100,000
Other working capital-52,900,00026,300,00065,000,00054,200,000
Other non-cash items25,500,00021,700,0007,400,000-18,400,000
Net cash from operating activities237,600,000388,800,000362,400,000376,500,000
Investments in property, plant and equipment-102,600,000-89,800,000-95,900,000-77,200,000
Acquisitions (net)0000
Purchases of investments-12,600,000-15,900,000-29,800,000-61,700,000
Sales/maturities of investments0000
Other investing activities0000
Net cash from investing activities-115,200,000-105,700,000-125,700,000-138,900,000
Net debt issuance00-41,300,000-25,600,000
Long-term net debt issuance00-41,300,000-25,600,000
Short-term net debt issuance0000
Net stock issuance-52,500,000-45,700,000-29,600,000-1,100,000
Net common stock issuance-52,500,000-45,700,000-29,600,000-1,100,000
Common stock issuance100,000100,0000-1,100,000
Common stock repurchased-52,600,000-45,800,000-29,600,0000
Net preferred stock issuance0000
Net dividends paid-278,200,000-245,700,000-197,400,000-194,000,000
Common dividends paid-278,200,000-245,700,000-197,400,000-194,000,000
Preferred dividends paid0000
Other financing activities-36,200,000-32,400,000-42,100,000-25,600,000
Net cash from financing activities-366,900,000-323,800,000-310,400,000-220,700,000
Effect of FX changes on cash6,600,000-1,200,000-100,0002,800,000
Net change in cash-237,900,000-41,900,000-73,800,00019,700,000
Cash at end of period275,700,000513,600,000555,500,000629,300,000
Cash at beginning of period513,600,000555,500,000629,300,000609,600,000
Operating cash flow237,600,000388,800,000362,400,000376,500,000
Capital expenditure-62,400,000-62,400,000-95,900,000-77,200,000
Free cash flow175,200,000326,400,000266,500,000299,300,000
Income taxes paid156,000,000131,500,00079,300,00026,100,000
Interest paid11,000,0009,200,0009,400,0008,600,000